Equities

PAVmed Inc

PAVM:NAQ

PAVmed Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.78
  • Today's Change-0.02 / -1.11%
  • Shares traded3.10k
  • 1 Year change-66.46%
  • Beta0.7566
Data delayed at least 15 minutes, as of May 23 2024 15:56 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.

  • Revenue in USD (TTM)3.02m
  • Net income in USD-71.05m
  • Incorporated2014
  • Employees107.00
  • Location
    PAVmed Inc360 Madison Avenue, 25Th FloorNEW YORK 10017United StatesUSA
  • Phone+1 (212) 949-4319
  • Fax+1 (302) 655-5049
  • Websitehttps://pavmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PetVivo Holdings Inc1.05m-10.63m11.10m25.00--10.85--10.61-0.8694-0.86940.08420.060.33751.212.0441,841.60-343.12-209.90-715.73-504.6451.4120.27-1,016.55-2,297.210.6169-2,268.840.1392--693.46260.32-73.83--51.73--
SINTX Technologies Inc2.78m-8.88m11.36m43.00--0.4765--4.09-1.95-1.950.37110.19430.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
ALR Technologies Inc9.49k-8.00m12.07m6.00------1,272.27-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
STRATA Skin Sciences Inc32.55m-11.36m13.36m99.00--1.42--0.4105-0.3248-0.32480.93070.2690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
Biotricity Inc11.63m-15.39m14.13m55.00------1.22-1.75-1.751.32-2.841.922.016.55211,408.70-240.40-303.46----65.5253.00-125.43-368.780.1012-0.5855----26.00--35.36------
Orgenesis Inc529.00k-45.66m16.51m146.00------31.20-1.53-1.530.0174-0.80720.010149.690.0493,623.29-98.12---338.48---660.87---9,744.05--0.0662-12.23-----98.53-50.94-271.82---17.71--
PAVmed Inc3.02m-71.05m16.98m107.00------5.63-9.08-9.080.3874-7.760.0588--64.1728,186.92-147.38-154.56---1,152.82-126.09---2,505.37-8,764.890.5301-8.321.82--550.40--25.76--55.51--
Dalrada Financial Corporation32.16m-21.34m17.47m0.00--1.98--0.5433-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Meihua International Medical Tech Co Ltd97.10m11.63m18.68m617.001.510.12011.550.19240.48560.48564.066.110.578846.661.31157,372.606.9112.268.1315.0534.1938.1411.9415.475.21--0.04750.00-6.055.1086.22-5.56-9.16--
QT Imaging Holdings Inc0.00-4.02m19.13m----0.88-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
Neuraxis Inc2.46m-14.63m19.19m17.00------7.80-3.78-3.780.5432------------------87.67---594.57-----23.75-----8.37---163.78------
Agape ATP Corp1.37m-2.39m19.79m21.00--5.41--14.45-0.0312-0.03120.0180.04750.3949.4130.7965,188.57-68.48---94.72--64.84---173.78--4.99--0.0204---22.92---24.61------
BioSig Technologies Inc27.00k-25.25m20.09m4.00------743.96-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
SANUWAVE Health Inc22.41m-17.26m21.20m31.00------0.9461-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
REMSleep Holdings Inc175.95k-1.80m22.79m6.00--33.67--129.55-0.0012-0.00120.00010.00050.08481.6911.20---86.95-152.40-108.40-317.98-411.78---1,025.38-2,317.521.63-18.540.0673---36.48--12.13--28.26--
Data as of May 23 2024. Currency figures normalised to PAVmed Inc's reporting currency: US Dollar USD

Institutional shareholders

14.35%Per cent of shares held by top holders
HolderShares% Held
First Manhattan Co LLCas of 31 Mar 2024425.00k4.63%
Ayrton Capital LLCas of 31 Dec 2023382.98k4.18%
The Vanguard Group, Inc.as of 31 Mar 2024298.74k3.26%
BlackRock Fund Advisorsas of 31 Mar 202474.91k0.82%
Geode Capital Management LLCas of 31 Mar 202463.36k0.69%
Valeo Financial Advisors LLCas of 31 Mar 202421.13k0.23%
SSgA Funds Management, Inc.as of 31 Mar 202420.98k0.23%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202411.75k0.13%
XML Financial LLCas of 31 Mar 202410.07k0.11%
Wells Fargo Clearing Services LLCas of 31 Mar 20247.02k0.08%
More ▼
Data from 30 Sep 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.